Athira Pharma Inc.

NASDAQ: ATHA · Real-Time Price · USD
0.33
-0.03 (-8.33%)
At close: Jun 09, 2025, 3:59 PM

Athira Pharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
48.44M 90.58M 95.97M 110.54M
Short-Term Investments
2.84M 56.84M 104.38M 143.22M
Long-Term Investments
n/a n/a 44.83M 65.94M
Other Long-Term Assets
686K 1.08M 475K 56K
Receivables
n/a 1.63M 1.23M 2.34M
Inventory
n/a n/a -1.23M -2.34M
Other Current Assets
3.57M 5.68M 5.96M n/a
Total Current Assets
54.84M 154.73M 207.53M 260.8M
Property-Plant & Equipment
3.25M 4.44M 5.32M 5.22M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
3.94M 5.52M 50.62M 71.21M
Total Assets
58.78M 160.25M 258.15M 332.01M
Account Payables
319K 129K 2.5M 567K
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
414K n/a 326K 288K
Other Current Liabilities
12.4M 23.8M 14.86M 6.24M
Total Current Liabilities
13.13M 28.84M 21.43M 9.29M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
803K 1.22M 1.58M 1.63M
Total Liabilities
13.94M 30.06M 23.02M 10.92M
Total Debt
1.22M 1.58M 1.91M 1.92M
Common Stock
4K 4K 4K 4K
Retained Earnings
-406.15M -309.21M -191.53M -95.89M
Comprehensive Income
1K -349K -1.96M -388K
Shareholders Equity
44.84M 130.19M 235.14M 321.08M
Total Investments
2.84M 56.84M 149.21M 209.16M